Literature DB >> 22327816

A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease.

Zhenyan Fu1, Yitong Ma, Xiang Xie, Ding Huang, Hong Yang, Tomohiro Nakayama, Naoyuki Sato.   

Abstract

BACKGROUND: CYP4A11 (cytochrome P450, family 4, subfamily A, polypeptide 11) converts arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which plays a crucial role in the modulation of cardiovascular homeostasis. The aim of the present study was to assess the association between the human CYP4A11 gene and coronary artery disease (CAD).
METHODS: A total of 361 patients with CAD and 315 controls were genotyped for 4 single-nucleotide polymorphisms (SNPs) of the human CYP4A11 gene (rs9332978, rs4660980, rs3890011, and rs1126742). The data were assessed for 3 groups: total participants, men, and women via case-control studies.
RESULTS: For total participants and men, the distribution of SNP3 (rs3890011) genotypes showed a significant difference between CAD and control participants (P = .030 and P = .013, respectively), the distribution of the recessive model of SNP3 (GG vs CC + GC) was significantly higher in CAD patients than in control participants (P = .011 and P = .014, respectively), the significant difference was retained after adjustment for covariates (for total participants, 95% confidence interval [CI]: 1.137-2.423, P = .009; and for males, 95% CI: 1.173-3.013, P = .009).
CONCLUSIONS: rs3890011 maybe a novel polymorphism of the CYP4A11 gene associated with CAD in a Han Chinese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327816     DOI: 10.1177/1076029611436197

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  7 in total

Review 1.  Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.

Authors:  Fan Fan; Ying Ge; Wenshan Lv; Matthew R Elliott; Yoshikazu Muroya; Takashi Hirata; George W Booz; Richard J Roman
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

Review 2.  20-HETE in the regulation of vascular and cardiac function.

Authors:  Petra Rocic; Michal Laniado Schwartzman
Journal:  Pharmacol Ther       Date:  2018-07-23       Impact factor: 12.310

Review 3.  Unraveling the Role of 12- and 20- HETE in Cardiac Pathophysiology: G-Protein-Coupled Receptors, Pharmacological Inhibitors, and Transgenic Approaches.

Authors:  Jonathan V Pascale; Pamela A Lucchesi; Victor Garcia
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-01       Impact factor: 3.271

Review 4.  Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis

Authors:  Imadeldin Elfaki; Rashid Mir; Fahad M Almutairi; Faisel M Abu Duhier
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

5.  Integrated pyroptosis measurement and metabolomics to elucidate the effect and mechanism of tangzhiqing on atherosclerosis.

Authors:  Rui Chen; Ting Chen; Zhihuan Zhou; Zhihui Song; Wanying Feng; Xintong Yang; Xianliang Wang; Bin Li; Xinya Ding; Han Zhang; Yi Wang
Journal:  Front Physiol       Date:  2022-09-12       Impact factor: 4.755

6.  Erratum to: The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China.

Authors:  Jin-Guo Zou; Yi-Tong Ma; Xiang Xie; Yi-Ning Yang; Shuo Pan; Dilare Adi; Fen Liu; Bang-Dang Chen
Journal:  Lipids Health Dis       Date:  2015-09-28       Impact factor: 3.876

7.  A Novel Polymorphism in the Promoter of the CYP4A11 Gene Is Associated with Susceptibility to Coronary Artery Disease.

Authors:  Svetlana Sirotina; Irina Ponomarenko; Alexander Kharchenko; Marina Bykanova; Anna Bocharova; Kseniya Vagaytseva; Vadim Stepanov; Mikhail Churnosov; Maria Solodilova; Alexey Polonikov
Journal:  Dis Markers       Date:  2018-02-01       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.